Adequan Injections For Dogs Uk

Adverse reactions in clinical studies transient pain at injection site transient diarrhea and abnormal bleeding were mild and self limiting.

Adequan injections for dogs uk.

Do not exceed the recommended dose or therapeutic regimen. The most commonly reported side effects were mild pain or swelling at the injection site diarrhea and delayed blood clotting that did not require treatment. Your veterinarian will determine the appropriate dose for your pet. Polysulfated glycosaminoglycan psgag sold under the brand name adequan is an injectable drug for dogs and horses that is used to alleviate the lameness pain and lowered range of motion caused by arthritis.

The recommended dosage is 2mg per pound of the dog s weight. However note that adequan has not been tested on pregnant or nursing dogs and should be used with caution in dogs that have had liver or kidney transplants or have a history of bleeding. It has been found that it provides relief from pain stiffness and lameness as effectively as the non steroidal anti inflammatory drugs commonly used in veterinary medicine. Just like any other injection one of the biggest perks of choosing adequan for dogs with arthritis problems is the fact that each injection will be quick and painless.

It has to be administered in a series of 8 injections. It is made of repeat disaccharide units comprising hexosamine and hexuronic acid and is similar to glycosaminoglycans already present in the cartilage. Cartrophen vet is given by injection to treat degenerative joint disease or arthritis in dogs. The approved label dose of adequan canine is 02 ml per pound of body weight by intramuscular injection only twice weekly for up to four weeks maximum of eight injections.

The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections. Normally a course of 4 injections is given at 5 7 day intervals. Use adequan canine early at the first clinical signs of oa before it progresses and cartilage is irreversibly damaged. We have no further studies or technical data supporting a use protocol beyond of the approved label dosing.

It should be used with caution in dogs with renal or hepatic impairment. Important safety information adequan canine should not be used in dogs who are hypersensitive to psgag or who have a known or suspected bleeding disorder. This dose of adequan canine should be injected intramuscularly twice a week for 4 weeks. Although improvement is generally observed after the second injection cartilage erosion ceases after the administration of all 8 injections.

Although there are cases where the injection site stays sensitive for a short period of time the process of using arthritis injections for dogs like adequan will be most likely. 2 do not exceed the recommended dose or therapeutic regimen.